✦ LIBER ✦

Second-line weekly paclitaxel in patients with inoperable non-small cell lung cancer who fail combination chemotherapy with cisplatin

✍ Scribed by Buccheri, Gianfranco; Ferrigno, Domenico

Book ID: 119318881
Publisher: Elsevier Science
Year: 2004
Tongue: English
Weight: 112 KB
Volume: 45
Category: Article
ISSN: 0169-5002
DOI: 10.1016/j.lungcan.2004.01.011

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Second-line chemotherapy with weekly pac

Second-line chemotherapy with weekly paclitaxel in patients with advanced non-small-cell lung cancer

✍ Luis Ángel León Mateos; Juan Fernando Cueva Bañuelos; María Teresa Curiel García 📂 Article 📅 2002 🏛 Springer Milan 🌐 Spanish ⚖ 49 KB

Second-line, low-dose, weekly paclitaxel

Second-line, low-dose, weekly paclitaxel in patients with stage IIIB/IV nonsmall cell lung carcinoma who fail first-line chemotherapy with carboplatin plus paclitaxel

✍ Mark A. Socinski; Michael J. Schell; Kamal Bakri; Amy Peterman; Ji-Hyun Lee; Pau 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 2 views

## Abstract ## BACKGROUND Second‐line chemotherapy with docetaxel improves survival and quality of life (QoL) in patients with nonsmall cell lung carcinoma (NSCLC) who fail first‐line platinum‐based regimens. The authors sought to determine the activity of second‐line, low‐dose, weekly paclitaxel

Phase I/II study of cisplatin combined w

Phase I/II study of cisplatin combined with weekly paclitaxel in patients with advanced non-small-cell lung cancer

✍ Yoshimura, N; Kudoh, S; Mukohara, T; Yamauchi, S; Yamada, M; Kawaguchi, T; Nakao 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 108 KB

794 Weekly paclitaxel (W-PAC) as second-

794 Weekly paclitaxel (W-PAC) as second-line therapy in cisplatin pretreated patients with advanced non-small cell lung cancer (NSCLC)

✍ G.L. Ceresoli; V. Gregorc; S. Cordio; K. Bencardino; A. Spreafico; C. Cozzarini; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Second-line (SL) weekly paclitaxel (P) i

Second-line (SL) weekly paclitaxel (P) in patients (pts) with advanced non-small cell lung cancer (NSCLC) failing first-line (FL) carboplatin/paclitaxel (C/P)

✍ Socinski, M.A; Kies, M; Unger, P; Peterman, A; Gillenwater, H.H; Schell, M; Bakr 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 231 KB

Cisplatin-based combination chemotherapy

Cisplatin-based combination chemotherapy for elderly patients with non-small-cell lung cancer

✍ Kaoru Kubota; Kiyoyuki Furuse; Masaaki Kawahara; Nagahisa Kodama; Mitsumasa Ogaw 📂 Article 📅 1997 🏛 Springer 🌐 English ⚖ 146 KB